Cite
HARVARD Citation
Perche, P. et al. (2023). Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis. Annals of pharmacotherapy. 57 (1), pp. 86-98. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Perche, P. et al. (2023). Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis. Annals of pharmacotherapy. 57 (1), pp. 86-98. [Online].